💜 Thanksgiving Food Drive for Shelter Pets Help Us Feed 1 Million Shelter Pets!
Redlining and Breast Cancer Survival: Why Where You Live Matters
Guest Contributor
Where a person lives can quietly, but powerfully, shape their chances of surviving breast cancer. A recent analysis of breast cancer survival and historical redlining in New York state shows that geography and history are still intertwined, with “where you live” becoming a critical breast cancer survival factor. The findings are sobering, yet they also point to real possibilities for change.
Redlining was a federal housing policy introduced in the 1930s that graded neighborhoods according to race and class. Black and immigrant communities were often labeled “hazardous,” effectively denying residents access to home loans and investment. Although this discriminatory practice was later outlawed by the Fair Housing Act of 1968, the consequences did not simply vanish. Decades of disinvestment left many of these neighborhoods with fewer healthcare facilities, limited access to healthy food, and greater exposure to environmental hazards like major highways and pollution. All of these elements contribute to the health of a community and, as this study suggests, to breast cancer outcomes as well.
Researchers led by Sarah Lima, PhD, at Georgetown University’s Lombardi Comprehensive Cancer Center set out to understand how this historical context continues to affect survival after a breast cancer diagnosis. They used data from the New York State Cancer Registry and examined more than 135,000 people diagnosed with breast cancer between 1995 and 2019. Each patient’s address at diagnosis was mapped onto historical redlining maps from the 1930s, which allowed the team to compare survival based on those original neighborhood grades.

In the late 1990s, the survival gap was stark. People diagnosed with breast cancer while living in the neighborhoods that had been most severely redlined faced a 75% higher risk of dying from any cause within five years than those living in the least redlined areas. The data did not specify whether these deaths were from breast cancer itself or other causes, but the difference in overall survival was pronounced. I found this detail striking because it highlights how much historical neighborhood conditions still echo in present-day health.
For a time, there were signs of real progress. By the mid-2000s, the survival gap had narrowed so that people in the most redlined areas had about a 48% higher risk of death within five years of diagnosis compared to those in the least redlined neighborhoods. This was still an unacceptably large disparity, but the direction of change seemed hopeful. Public health advocates and researchers pointed to increased mammography screening, broader health insurance coverage, and growing community-based outreach as likely contributors. These efforts appeared to be chipping away at long-standing inequalities in cancer care and outcomes.
Yet the trend did not continue. After 2015, the survival gap began to widen again. In the most recent years studied, residents of the most heavily redlined neighborhoods had about a 63% higher risk of dying from any cause within five years than those living in the least redlined areas. The pattern was visible across racial and ethnic groups. That finding suggests that while racism and unequal treatment in healthcare remain important factors, neighborhood conditions themselves have a broad, independent impact on survival.
The researchers believe that access is at the heart of this renewed divide. When new breast cancer treatments become available, people in wealthier, historically favored neighborhoods are often the first to benefit. Those communities may have more cancer specialists, better resourced hospitals, and health insurance plans that more readily cover new therapies. Lima notes that people in non-redlined neighborhoods may also have social advantages that are harder to measure, such as personal relationships with physicians or others in the healthcare field who can alert them to new treatments and clinical trials.
The study team paid particular attention to people with hormone receptor-positive breast cancer, one of the most common forms of the disease. The widening survival gap was especially noticeable in this group. Although the cause of death could not be definitively tied to breast cancer in their analysis, the timing of the widening gap raised important questions. CDK4/6 inhibitors, a class of targeted drugs that can be very effective for certain hormone receptor-positive breast cancers, became available starting in 2015. PARP inhibitors, which can also be important in some breast cancer treatment plans, were approved in 2018. The researchers theorize that people’s access to these newer therapies may vary according to the historical redlining grade of their neighborhood. In other words, approval of a drug does not guarantee equal access to it.
This work reinforces the idea that structural forces, rather than individual choices, play a major role in health. That said, there are still steps people can consider in their own lives while broader reforms move forward. Physical activity, even something as simple as regular walking, has been shown to improve survival after a breast cancer diagnosis. The study notes that people in redlined neighborhoods are less likely to be physically active, which may be tied to fewer green spaces, concerns about safety, or limited time and resources. These realities show how a person’s environment shapes the “healthy choices” available to them.
Social support is another powerful influence on quality of life and, potentially, on survival. Support can look different for everyone. It might be leaning on family and friends, seeking out a cancer support group, or connecting with neighbors and community organizations. For people concerned about their care, asking questions can be especially important. Patients can talk with their oncology team about whether newer treatment options are appropriate for their type and stage of breast cancer and whether clinical trials are available. They can also ask if a social worker or financial navigator can help with treatment costs, transportation, or insurance challenges that could limit access.

Advocacy offers another avenue for action. Community members and survivors can choose to get involved with organizations that push for policies aimed at expanding access to care and improving neighborhood health. Groups that focus on breast cancer policy and research funding may help draw attention to inequities uncovered in studies like this one. While advocacy may not change circumstances overnight, it contributes to the policy solutions that many experts believe are necessary to close survival gaps tied to geography and history.
One of the most hopeful findings in this research is that the survival gap did not move in only one direction. It shrank significantly between the late 1990s and the mid-2000s, which suggests that coordinated efforts in screening, insurance coverage, and outreach can reduce disparities. The fact that the gap then widened again serves as a warning that progress is fragile and requires sustained attention. Lima views the study as additional evidence that society needs to invest in making neighborhoods healthier. Access to safe spaces for exercise, comprehensive medical care, and reliable insurance should not depend on how a neighborhood was graded on a map nearly a century ago. As this research makes clear, the long shadow of redlining continues to shape breast cancer survival, yet it also shows that with focused policies and equitable investment, change is both necessary and possible.
Read more at https://www.breastcancer.org/news/redlining-breast-cancer-survival